Ingevity Corporation
NGVT
$46.91
-$0.45-0.95%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -19.61% | -15.49% | -18.93% | -13.37% | -3.10% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -19.61% | -15.49% | -18.93% | -13.37% | -3.10% |
| Cost of Revenue | -34.82% | -22.08% | -18.67% | -8.31% | 5.45% |
| Gross Profit | 36.44% | 0.70% | -19.48% | -23.54% | -25.40% |
| SG&A Expenses | -10.07% | -3.25% | -19.92% | -2.88% | -21.12% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -30.91% | -19.85% | -18.64% | -7.88% | 1.00% |
| Operating Income | 116.90% | 4.06% | -20.15% | -37.40% | -35.01% |
| Income Before Tax | 105.71% | -529.60% | -801.47% | -212.17% | -881.73% |
| Income Tax Expenses | 79.03% | -544.93% | -517.21% | -218.66% | -1,007.32% |
| Earnings from Continuing Operations | 114.21% | -525.40% | -899.15% | -210.45% | -848.72% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 114.21% | -525.40% | -899.15% | -210.45% | -848.72% |
| EBIT | 116.90% | 4.06% | -20.15% | -37.40% | -35.01% |
| EBITDA | 59.56% | -7.69% | -17.70% | -27.67% | -11.92% |
| EPS Basic | 114.17% | -523.96% | -899.99% | -213.21% | -873.56% |
| Normalized Basic EPS | 447.62% | 7.40% | -58.57% | -105.28% | -74.26% |
| EPS Diluted | 114.04% | -527.54% | -905.15% | -214.39% | -877.77% |
| Normalized Diluted EPS | 443.13% | 7.89% | -58.32% | -105.33% | -74.06% |
| Average Basic Shares Outstanding | 0.28% | 0.33% | -0.10% | -2.43% | -3.21% |
| Average Diluted Shares Outstanding | 1.10% | -0.12% | -0.72% | -3.41% | -3.98% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
